Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening Trial

Mary M Pasquinelli; Kevin L Kovitz; Matthew Koshy; Martha G Menchaca; Li Liu; Robert Winn; Lawrence E Feldman

doi:10.1001/jamaoncol.2018.2823

Outcomes From a Minority-Based Lung Cancer Screening Program vs the National Lung Screening Trial

JAMA Oncol. 2018 Sep 1;4(9):1291-1293. doi: 10.1001/jamaoncol.2018.2823.

Authors

Mary M Pasquinelli¹, Kevin L Kovitz², Matthew Koshy³, Martha G Menchaca⁴, Li Liu⁵, Robert Winn^{2

6}, Lawrence E Feldman⁷

Affiliations

¹ Department of Medicine, University of Illinois at Chicago.
² Division of Pulmonary, Critical Care, Sleep and Allergy, University of Illinois at Chicago.
³ Department of Radiation Oncology, University of Illinois at Chicago.
⁴ Department of Radiology, University of Illinois at Chicago.
⁵ School of Public Health, Division of Epidemiology and Biostatistics, University of Illinois at Chicago.
⁶ University of Illinois Cancer Center, Chicago.
⁷ Division of Hematology/Oncology, University of Illinois at Chicago.

Abstract

This population-based study assesses demographic characteristics, CT scan findings, and lung cancer detection in minority populations compared with outcomes from the National Lung Screening Trial.

MeSH terms

Aged
Black or African American / statistics & numerical data*
Cohort Studies
Early Detection of Cancer / methods
Early Detection of Cancer / statistics & numerical data*
Female
Humans
Lung Neoplasms / diagnosis*
Lung Neoplasms / diagnostic imaging
Lung Neoplasms / ethnology
Male
Middle Aged
Minority Groups*
Sensitivity and Specificity
Tomography, X-Ray Computed